Pfizer has won the week-long bidding war for Metsera with an upwardly revised up-to-$10 billion offer matching that of rival Novo Nordisk—and more than a little help from Washington.
51m
Novo Nordisk slashes Wegovy prices in India by up to 37% to boost sluggish sales of weight-loss drug
According to renowned endocrinologist Dr Shashank Joshi, a steep cut in the prices of Wegovy will help improve access and affordability. “But it has to be cautioned that weight loss drugs are not ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback